Neuroimaging and Psychosocial Addiction Treatment

An Integrative Guide for Researchers and Clinicians
2015. Auflage 2015
ISBN: 978-1-137-36264-3
Verlag: Palgrave MacMillan UK

Buch, Englisch, 270 Seiten, Format (B × H): 137 mm x 218 mm, Gewicht: 4728 g

Using an innovative translational approach between the work of experimental scientists and clinical practitioners this book addresses the current, modest, understanding of how and why addiction treatment works. Through bridging this gap it provides a critical insight into why people react as they do in the context of addiction treatment.

Zielgruppe

Research

Autoren/Hrsg.

Feldstein Ewing, Sarah W

Witkiewitz, Katie

Filbey, Francesca M

Fachgebiete

• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie Suchttherapie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie
• Sozialwissenschaften Psychologie Allgemeine Psychologie Biologische Psychologie, Neuropsychologie

Inhaltsverzeichnis

"Preface

PART I: INTRODUCTION
1. Translational Approaches to Addiction Treatment; Sarah W. Yip, Kathleen M. Carroll and Marc N. Potenza
2. Fundamentals of Addiction Neuroscience; Ariel Ketcherside and Francesca M. Filbey
PART II: TRANSLATIONAL APPROACHES WITH ADULTS
3. Using Clinical Neuroscience to Understand Addiction Treatment; Joseph P. Schacht and Kent E. Hutchison
4. Neuropsychopharmacology in Addiction Treatment; Lara A. Ray, Kelly E. Courtney, Daniel Roche, and Karen Miotto
5. The Promise of Repetitive Transcranial Magnetic Stimulation to Treat Addiction; Rachel A. Rabin, Daniel M. Blumberger, Zafiris J. Daskalakis, Tony P. George, and Mera S. Barr
6. Neuroscience and Mindfulness-Based Interventions: Translating Neural Mechanisms to Addiction Treatment; Matthew R. Pearson, Corey R. Roos, David B. Brown, and Katie Witkiewitz
7. New Approaches to Treating Cannabis Dependence: From Neuroscience to Practice; Janna Cousijn and Francesca M. Filbey8. Morphometric Biomarkers of Addiction and Treatment Response; Teresa R. Franklin, Joel Mumma, Kanchana Jagannathan, Reagan R. Wetherill, and Anna Rose Childress
9. Neural Mechanisms Supporting the Regulation of Cigarette Craving; Stephen J. Wilson
10. Neuroeconomics: Implications for Understanding and Treating Addictive Behavior; David P. Jarmolowicz, Derek D. Reed, and Warren K. Bickel
11. Using Neuroimaging to Improve Emotion Regulation Treatments for Substance Use Disorders; Claire E. Wilcox and Bryon Adinoff
PART III: TRANSLATIONAL APPROACHES WITH ADOLESCENTS
12. Introduction to Functional Brain Connectivity: Potential Contributions to Understanding Adolescent Vulnerability to Substance Abuse; Monique Ernst, Elizabeth A. Hale, Nicholas Balderston, Salvatore Torrisi
13. Approaching Adolescent Substance Abuse Treatment through Neuroscience; Anita Cservenka, Tam T. Nguyen-Louie, Susan F. Tapert, and Bonnie J. Nagel
14. Prenatal Exposure to Maternal Cigarette Smoking, Addiction and the Offspring Brain; Tomáš Paus and Zdenka Pausova
15. Deconstructing the Neural Substrates of Motivational Interviewing: A New Look at Unresolved Questions; Sarah W. Feldstein Ewing, Hollis Karoly, and Jon M. Houck
16. Neural Influences in Contingency Management for Adolescent Substance Use; Catherine Stanger and Hugh Garavan
PART IV: EPILOGUE
17. How to Practically Apply Lessons Learned from Translational Neuroscience to Intervention Development: Ideas for the Road Ahead; Sarah W. Feldstein Ewing, Katie Witkiewitz, and Francesca M. Filbey

Über Autor(innen)

Bryon Adinoff, VA North Texas Health Care System and UT Southwestern Medical Center, USA
Nicholas L. Balderston, National Institute of Mental Health, National Institutes of Health, USA
Mera S. Barr, MSc, University of Toronto, Canada
Warren K. Bickel, Virginia Tech Carilion Research Institute, USA
Daniel M. Blumberger, University of Toronto, Canada
David B. Brown, University of New Mexico, USA
Kathleen M. Carroll, Yale University School of Medicine, USA
Anna Rose Childress, University of Pennsylvania, USA
Kelly E. Courtney, University of California, USA
Janna Cousijn, Utrecht University, the Netherlands
Anita Cservenka, Oregon Health & Science University, USA
Zafiris J. Daskalakis, University of Toronto, Canada
Monique Ernst, National Institute of Mental Health, National Institutes of Health, USA
Sarah W. Feldstein Ewing, University of New Mexico, USA
Francesca M. Filbey, University of Texas at Dallas, USA
Teresa R. Franklin, University of Pennsylvania, USA
Hugh Garavan, Universityof Vermont, USA
Tony P. George, University of Toronto, Canada
Elizabeth A. Hale, National Institute of Mental Health, National Institutes of Health, USA
Jon M. Houck, University of New Mexico, USA
Kent E. Hutchison, University of Pennsylvania, USA
David P. Jarmolowicz, University of Kansas, USA
Hollis C. Karoly, University of Colorado Boulder, USA
Ariel Ketcherside, University of Texas at Dallas, USA
Karen A. Miotto, University of California, USA
Joel Mumma, Georgia Institute of Technology, USA
Bonnie J. Nagel, Oregon Health & Science University, USA
Tam T. Nguyen-Louie, San Diego State University, USA
Tomá Paus, University of Toronto, Canada
Zdenka Pausova, Senior Scientist, University of Toronto
Matthew R. Pearson, University of New Mexico, USA
Marc N. Potenza, Yale School of Medicine, USA
Rachel A. Rabin, University of Toronto, Canada
Lara A. Ray, University of California, USA
Derek D. Reed, University of Kansas, USA
Daniel J. O. Roche, University of California, USA
Corey R. Roos,University of New Mexico,USA
Joseph P. Schacht, Medical University of South Carolina, USA
Catherine Stanger, Geisel School of Medicine at Dartmouth, USA
Susan F. Tapert, VA San Diego Healthcare System, USA
Salvatore Torrisi, National Institute of Mental Health, National Institutes of Health, USA
Reagan R. Wetherill, University of Pennsylvania, USA
Claire E. Wilcox, University of New Mexico, USA
Stephen J. Wilson, The Pennsylvania State University, USA
Katie Witkiewitz, University of New Mexico, USA
Sarah W. Yip, Yale School of Medicine, USA